Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -16.20%-4.38M | -21.64%8.94M | 376.78%30.78M | -277.45%-26.54M | -230.20%-23.06M | -117.27%-3.77M | 154.79%11.4M | -196.64%-11.12M | -71.28%14.96M | -73.69%17.71M |
| Net profit before non-cash adjustment | 196.75%1.13M | -94.81%42K | -80.87%373K | -110.08%-936.64K | -241.54%-2.52M | -200.77%-1.17M | -76.30%809K | -33.47%1.95M | -46.32%9.29M | 170.66%1.78M |
| Total adjustment of non-cash items | -14.49%2M | 49.07%2.01M | 17.95%2.84M | 203.41%7.56M | 41.18%1.47M | 690.20%2.34M | 22.48%1.35M | 4,276.36%2.41M | -59.50%2.49M | 174.40%1.04M |
| -Depreciation and amortization | ---- | ---- | ---- | 4.18%6.05M | ---- | ---- | ---- | ---- | 13.97%5.81M | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 95.61%-238.68K | ---- | ---- | ---- | ---- | -232.55%-5.43M | ---- |
| -Disposal profit | ---- | ---- | ---- | -6,133.61%-278.57K | ---- | ---- | ---- | ---- | -96.33%4.62K | ---- |
| -Pension and employee benefit expenses | ---- | ---- | ---- | 7.65%174.89K | ---- | ---- | ---- | ---- | 8.24%162.45K | ---- |
| -Other non-cash items | -14.49%2M | 49.07%2.01M | 17.95%2.84M | -4.89%1.86M | -952.38%-4.24M | 690.20%2.34M | 22.48%1.35M | 4,276.36%2.41M | -19.27%1.95M | 109.69%497.54K |
| Changes in working capital | -52.19%-7.51M | -25.57%6.88M | 278.12%27.57M | -1,144.98%-33.17M | -247.77%-22M | -124.25%-4.93M | 136.49%9.24M | -129.81%-15.48M | -88.91%3.17M | -79.10%14.89M |
| -Change in receivables | ---- | ---- | ---- | -97.83%210.38K | ---- | ---- | ---- | ---- | 3,662.05%9.68M | ---- |
| -Change in inventory | ---- | ---- | ---- | -495.72%-32.69M | ---- | ---- | ---- | ---- | -85.48%8.26M | ---- |
| -Change in payables | ---- | ---- | ---- | 95.32%-690.32K | ---- | ---- | ---- | ---- | 48.24%-14.76M | ---- |
| -Changes in other current assets | 8.73%-5.65M | -106.62%-258K | 243.06%31.6M | -286.11%-33.38M | -140.12%-9M | -136.77%-6.19M | 149.22%3.9M | -64.74%-22.09M | --17.94M | --22.43M |
| -Changes in other current liabilities | -248.60%-1.86M | 33.45%7.14M | -161.01%-4.03M | 101.88%277K | -71.51%-12.94M | -64.43%1.25M | 130.71%5.35M | -0.93%6.61M | ---14.76M | ---7.54M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | 0 | 0 | ||||||||
| Interest paid (cash flow from operating activities) | -36.55%426.18K | 16.96%671.68K | ||||||||
| Interest received (cash flow from operating activities) | 53.66%126K | 13.01%139K | -19.11%127K | -36.55%426.18K | -36.88%64.18K | -56.61%82K | -4.65%123K | -37.70%157K | 671.68K | 101.68K |
| Tax refund paid | 37.47%-272K | 86.84%-60K | 17.83%-258K | 12.53%-1.41M | -572.94%-202.56K | -167.13%-435K | 64.29%-456K | 66.95%-314K | 90.20%-1.61M | 89.77%-30.1K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | -15.5K | -15.5K | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -9.78%-4.52M | -18.57%9.02M | 371.77%30.65M | -296.43%-27.54M | -230.54%-23.21M | -118.19%-4.12M | 150.41%11.07M | -153.61%-11.28M | -61.31%14.02M | -73.69%17.78M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -46.15%-133K | -2,478.18%-2.62M | 21.14%-250K | 87.10%-447.28K | 79.98%-149.28K | 90.94%-91K | 108.18%110K | 15.01%-317K | 93.86%-3.47M | 52.42%-745.67K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Investing cash flow | -46.15%-133K | -2,478.18%-2.62M | 21.14%-250K | 87.10%-447.28K | 79.98%-149.28K | 90.94%-91K | 108.18%110K | 15.01%-317K | 93.86%-3.47M | 61.41%-745.67K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -71.68%271K | -17.55%-9.22M | -296.13%-21.14M | 212.37%28.89M | 349.93%25M | 103.67%957K | -141.23%-7.85M | 224.43%10.78M | -299.60%-25.71M | 78.23%-10M |
| Increase or decrease of lease financing | 17.21%-101K | -48.72%-174K | 32.04%-70K | -6.04%-463.99K | -11.35%-121.99K | -11.93%-122K | -5.41%-117K | 4.63%-103K | 21.39%-437.56K | 89.72%-109.56K |
| Cash dividends paid | ---- | ---- | ---- | 25.00%-5.23M | -25.00%135 | ---- | ---- | ---- | 33.33%-6.98M | 124.66%180 |
| Interest paid (cash flow from financing activities) | 29.77%-342K | 10.09%-499K | -17.54%-670K | 12.91%-2.25M | -49.18%-642.49K | 40.97%-487K | 27.64%-555K | -0.71%-570K | 12.78%-2.59M | 50.33%-430.67K |
| Financing cash flow | 96.48%-172K | -16.18%-9.9M | -316.52%-21.88M | 158.62%20.94M | 329.88%24.24M | 85.62%-4.89M | -146.92%-8.52M | 208.24%10.11M | -3,107.22%-35.72M | 77.99%-10.54M |
| Net cash flow | ||||||||||
| Beginning cash position | -11.99%23.48M | 12.32%26.98M | -27.64%18.46M | -49.66%25.51M | -7.52%17.59M | -14.94%26.68M | -34.22%24.02M | -49.66%25.51M | -29.64%50.68M | -42.21%19.02M |
| Current changes in cash | 46.94%-4.83M | -231.40%-3.5M | 671.88%8.52M | 71.98%-7.05M | -86.54%873.82K | 26.35%-9.1M | 151.69%2.66M | 89.47%-1.49M | -17.86%-25.16M | -63.45%6.49M |
| End cash Position | 6.08%18.66M | -11.99%23.48M | 12.32%26.98M | -27.64%18.46M | -27.64%18.46M | -7.52%17.59M | -14.94%26.68M | -34.22%24.02M | -49.66%25.51M | -49.66%25.51M |
| Free cash flow | -9.82%-4.66M | -42.22%6.3M | 362.18%30.4M | -375.52%-28.31M | -237.13%-23.36M | -119.72%-4.25M | 146.42%10.9M | -140.56%-11.6M | 150.77%10.27M | -74.20%17.04M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.